Cargando…

Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases

Cardiometabolic diseases are frequently polygenic in architecture, comprising a large number of risk alleles with small effects spread across the genome(1–3). Polygenic scores (PGS) aggregate these into a metric representing an individual’s genetic predisposition to disease. PGS have shown promise f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritchie, Scott C., Lambert, Samuel A., Arnold, Matthew, Teo, Shu Mei, Lim, Sol, Scepanovic, Petar, Marten, Jonathan, Zahid, Sohail, Chaffin, Mark, Liu, Yingying, Abraham, Gad, Ouwehand, Willem H., Roberts, David J., Watkins, Nicholas A., Drew, Brian G., Calkin, Anna C., Di Angelantonio, Emanuele, Soranzo, Nicole, Burgess, Stephen, Chapman, Michael, Kathiresan, Sekar, Khera, Amit V., Danesh, John, Butterworth, Adam S., Inouye, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574944/ https://www.ncbi.nlm.nih.gov/pubmed/34750571 http://dx.doi.org/10.1038/s42255-021-00478-5

Ejemplares similares

Machine learning optimized polygenic scores for blood cell traits identify sex-specific trajectories and genetic correlations with disease
por: Xu, Yu, et al.
Publicado: (2022)

Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer’s disease
por: Paranjpe, Manish D., et al.
Publicado: (2022)

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
por: Khera, Amit V., et al.
Publicado: (2018)

Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses
por: Sun, Luanluan, et al.
Publicado: (2021)

Clinical utility of polygenic scores for cardiometabolic disease in Arabs
por: Shim, Injeong, et al.
Publicado: (2023)

Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores
por: Homburger, Julian R., et al.
Publicado: (2019)

Polygenic basis and biomedical consequences of telomere length variation
por: Codd, Veryan, et al.
Publicado: (2021)

Association of Acculturation and Cardiometabolic Disease Among Immigrants of South Asian Ancestry
por: Kathiresan, Nikhil, et al.
Publicado: (2023)

Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals
por: Huang, Qin Qin, et al.
Publicado: (2022)

Associations of cardiometabolic polygenic risk scores with cardiovascular disease in African Americans
por: Tsegaselassie, Workalemahu, et al.
Publicado: (2023)

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
por: Fahed, Akl C., et al.
Publicado: (2020)

The influence of rare variants in circulating metabolic biomarkers
por: Riveros-Mckay, Fernando, et al.
Publicado: (2020)

Red cell distribution width and its polygenic score in relation to mortality and cardiometabolic outcomes
por: Pan, Jingxue, et al.
Publicado: (2023)

Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants
por: Ritchie, Scott C., et al.
Publicado: (2023)

Polygenic risk score for Alzheimer’s disease and trajectories of cardiometabolic risk factors in children
por: Korologou-Linden, Roxanna, et al.
Publicado: (2019)

Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI
por: Georgi, Benjamin, et al.
Publicado: (2019)

Using Polygenic Risk Scores for Prioritizing Individuals at Greatest Need of a Cardiovascular Disease Risk Assessment
por: Chung, Ryan, et al.
Publicado: (2023)

Whole-exome sequencing identifies rare genetic variants associated with human plasma metabolites
por: Bomba, Lorenzo, et al.
Publicado: (2022)

Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke
por: Abraham, Gad, et al.
Publicado: (2019)

Author Correction: Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke
por: Abraham, Gad, et al.
Publicado: (2020)

The potential of polygenic scores to improve cost and efficiency of clinical trials
por: Fahed, Akl C., et al.
Publicado: (2022)

The Polygenic and Monogenic Basis of Blood Traits and Diseases
por: Vuckovic, Dragana, et al.
Publicado: (2020)

Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimates
por: Goudswaard, Lucy J., et al.
Publicado: (2021)

Genetic Architecture of Untargeted Lipidomics in Cardiometabolic-Disease Patients Combines Strong Polygenic Control and Pleiotropy
por: Brial, Francois, et al.
Publicado: (2022)

Predicting Risk of Hypertension Among Childhood Cancer Survivors: A Polygenic Score to the Rescue?
por: Agrawal, Saaket, et al.
Publicado: (2021)

Fast Principal Component Analysis of Large-Scale Genome-Wide Data
por: Abraham, Gad, et al.
Publicado: (2014)

Look, no hands! Spectral biomarkers from genetic association studies
por: Inouye, Michael, et al.
Publicado: (2013)

Associations of polygenic inheritance of physical activity with aerobic fitness, cardiometabolic risk factors and diseases: the HUNT study
por: Tynkkynen, Niko Paavo, et al.
Publicado: (2023)

Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history
por: Hassanin, Emadeldin, et al.
Publicado: (2023)

Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences
por: Rosenberg, Noah A, et al.
Publicado: (2018)

Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease
por: Emdin, Connor A., et al.
Publicado: (2017)

The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases
por: Jurrjens, Aaron W, et al.
Publicado: (2023)

New Insights into Polygenic Score–Lifestyle Interactions for Cardiometabolic Risk Factors from Genome-Wide Interaction Analyses
por: D’Urso, Shannon, et al.
Publicado: (2023)

Single-cell transcriptomics: an emerging tool in the study of cardiometabolic disease
por: Khera, Amit V, et al.
Publicado: (2014)

A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
por: Leal, Luis G., et al.
Publicado: (2020)

ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study
por: Gill, Dipender, et al.
Publicado: (2020)

A Polygenic Approach to the Study  of Polygenic Diseases
por: Lvovs, D., et al.
Publicado: (2012)

Genetically personalised organ-specific metabolic models in health and disease
por: Foguet, Carles, et al.
Publicado: (2022)

Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research
por: Lopez-Pineda, Arturo, et al.
Publicado: (2022)

Future Preventive Gene Therapy of Polygenic Diseases from a Population Genetics Perspective
por: Oliynyk, Roman Teo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m1mqgq92d87v6qtlpl4ejc89m4